Navigation Links
Lifecycle Biotechnologies Celebrates 20 Years of Business with Its Chata Biosystems Brand
Date:8/14/2019

Chata was founded in 1999 in Fort Collins, Colorado to focus on prepackaged mobile phases for QC laboratories. After gaining a few significant clients, Lifecycle purchased the company with the vision to reinvent Chata from its laboratory sciences approach into a valued supplier of manufacturing processing solutions, including reagents for tissue processing. Chata quickly outgrew the original location and moved to its current Loveland, Colorado location in 2013. Several key and still active members of the team at Chata joined between 2004 and 2010. During these years, Chata developed the CHEM+NECT and CHEM+PROTECT delivery systems which formed the backbone of the company and continued to expand.

“Through the years, Chata has been able to identify and grow new, blue ocean markets to sustain growth and has more than doubled in size since we acquired it,” said Cody Yarborough, CEO of Lifecycle Biotechnologies. “Some of the near-term initiatives are entry into the molecular diagnostic reagent markets, global expansion, further vertical integration and continue growth of our animal science presence. I’m excited to see what Chata will look like in the next few years; I think we will need more manufacturing and warehouse space, more talent to drive new markets and better weaponization of our supply chain as Chata remains a very dynamic company with a bunch of different growth paths.”

From 2011 to today, Chata continued to evolve and launch products to expand and better support the markets it serves including…

  • the development and commercialization of the CHEM+POUR Bag, a bag designed to support aseptic manufacturing and to be an evolution and more sustainable option to a bottle,
  • the addition of semi-automated filling equipment to more efficiently and microbiologically fill the CHEM+NECT and CHEM+POUR Bags,
  • as well as adding powdered biochemicals to support non-aqueous chemical needs, autoclavable and pressurized pump systems, more robust and cleaner cubitainer alternatives, and expanded into numerous previously unserved markets.

Chata’s approach has always been based in their custom-engineered packaging systems, being experts at manufacturing custom and semi-custom aqueous reagents, chemicals, and medias under cGMP procedures with the highest level of quality. With their 20 years’ worth of experience manufacturing chemicals, reagents, and medias they offer thousands of different product formulations.

To learn more about the Chata Biosystems products or the other Lifecycle brands, Boval BioSolutions and VI Plastics, and to experience for yourself the difference they can make for you and your facility, please contact Lifecycle Biotechnologies at info(at)lifecyclebio(dot)com, 817.840.7855, or http://www.lifecyclebio.com.

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for over 40 years. Lifecycle’s products are the beginning of the lifecycle of the lifesaving and life-enhancing medical products used globally today. As a leading life sciences tools and service supplier, Lifecycle fully understands the critical role its products play in many of the world’s leading pharmaceuticals, medical devices, biologics, cell- and tissue-based products and many other medical products. While Lifecycle’s products aren’t used to diagnose, treat, or cure patients, without their contribution, none of this would be possible.

Read the full story at https://www.prweb.com/releases/lifecycle_biotechnologies_celebrates_20_years_of_business_with_its_chata_biosystems_brand/prweb16489338.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
2. Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
3. Wyle Wins NASAs Fully Integrated Lifecycle Mission Support Services Contract
4. Model of viral lifecycle could help in finding a cure for hepatitis B
5. PointCross announces SaaS offerings on the cloud to span the entire lifecycle of eData submissions to FDA
6. Lifecycle Biotechnology Today Announced the Hiring of Aaron Benz as Business Development Manager for their Chemical and Reagent Brand, Chata Biosystems
7. Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform
8. Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
9. Lifecycle Biotechnologies Celebrates 40 Years of Business with its Boval BioSolutions Brand
10. Lifecycle Biotechnologies Names Aaron Schieving Vice President
11. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 edition of ... is now available online on the company’s global website. The Bridge features current ... fluorescence and imaging, and presents articles, scientific papers and news reports. , ...
(Date:9/24/2019)... ... 24, 2019 , ... Drug resistance has been declared as one of the ... becoming one of the most serious concerns. Hong Kong cannot be spared from the ... (CA-MRSA), or a seven-fold of the figure in 2007 – the year the disease ...
(Date:9/24/2019)... ... 24, 2019 , ... Personalized Stem Cells, Inc ... for clinical trial sites and physician investigators. The clinical trial sites are ... , Clinical trial sites are currently located in San Diego and Los Angeles ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three ... led by faculty at South Dakota School of Mines & Technology that ... that attach to surfaces to form a slimy and yet strong layer which is ...
Breaking Biology Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... VISTAAR released ADVISORY Playbooks to ... as re-assurance / 2nd opinion to their internal strategies they formed for developing or ... going into new markets, or planning to change their product elements and want to ...
(Date:9/14/2019)... ... 13, 2019 , ... Two studies presented at the annual ... of gene therapy and advances to decrease nerve damage using Fluorescence image-guided surgery. ... storage diseases (LSD) are among the most dismal of prognosis in all of ...
(Date:9/8/2019)... ... September 06, 2019 , ... ... Nanosens Innovations have each authorized the respective companies to proceed with a proposed ... with the Nanosens brand representing a series of products leveraging the CRISPR-Chip technology. ...
Breaking Biology News(10 mins):